Literature DB >> 25286850

Structures of human constitutive nitric oxide synthases.

Huiying Li1, Joumana Jamal1, Carla Plaza1, Stephanie Hai Pineda1, Georges Chreifi1, Qing Jing2, Maris A Cinelli2, Richard B Silverman2, Thomas L Poulos1.   

Abstract

Mammals produce three isoforms of nitric oxide synthase (NOS): neuronal NOS (nNOS), inducible NOS (iNOS) and endothelial NOS (eNOS). The overproduction of NO by nNOS is associated with a number of neurodegenerative disorders; therefore, a desirable therapeutic goal is the design of drugs that target nNOS but not the other isoforms. Crystallography, coupled with computational approaches and medicinal chemistry, has played a critical role in developing highly selective nNOS inhibitors that exhibit exceptional neuroprotective properties. For historic reasons, crystallography has focused on rat nNOS and bovine eNOS because these were available in high quality; thus, their structures have been used in structure-activity-relationship studies. Although these constitutive NOSs share more than 90% sequence identity across mammalian species for each NOS isoform, inhibitor-binding studies revealed that subtle differences near the heme active site in the same NOS isoform across species still impact enzyme-inhibitor interactions. Therefore, structures of the human constitutive NOSs are indispensible. Here, the first structure of human neuronal NOS at 2.03 Å resolution is reported and a different crystal form of human endothelial NOS is reported at 1.73 Å resolution.

Entities:  

Keywords:  nitric oxide synthase

Mesh:

Substances:

Year:  2014        PMID: 25286850      PMCID: PMC4188008          DOI: 10.1107/S1399004714017064

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  26 in total

1.  Blu-Ice and the Distributed Control System: software for data acquisition and instrument control at macromolecular crystallography beamlines.

Authors:  Timothy M McPhillips; Scott E McPhillips; Hsiu-Ju Chiu; Aina E Cohen; Ashley M Deacon; Paul J Ellis; Elspeth Garman; Ana Gonzalez; Nicholas K Sauter; R Paul Phizackerley; S Michael Soltis; Peter Kuhn
Journal:  J Synchrotron Radiat       Date:  2002-11-01       Impact factor: 2.616

Review 2.  Mammalian nitric oxide synthases.

Authors:  D J Stuehr; O W Griffith
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1992

3.  Nitric oxide synthase regulatory sites. Phosphorylation by cyclic AMP-dependent protein kinase, protein kinase C, and calcium/calmodulin protein kinase; identification of flavin and calmodulin binding sites.

Authors:  D S Bredt; C D Ferris; S H Snyder
Journal:  J Biol Chem       Date:  1992-06-05       Impact factor: 5.157

Review 4.  Endogenous nitric oxide: physiology, pathology and clinical relevance.

Authors:  S Moncada; E A Higgs
Journal:  Eur J Clin Invest       Date:  1991-08       Impact factor: 4.686

5.  Use of TLS parameters to model anisotropic displacements in macromolecular refinement.

Authors:  M D Winn; M N Isupov; G N Murshudov
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2001-01

6.  Crystal structures of zinc-free and -bound heme domain of human inducible nitric-oxide synthase. Implications for dimer stability and comparison with endothelial nitric-oxide synthase.

Authors:  H Li; C S Raman; C B Glaser; E Blasko; T A Young; J F Parkinson; M Whitlow; T L Poulos
Journal:  J Biol Chem       Date:  1999-07-23       Impact factor: 5.157

7.  Structural characterization of nitric oxide synthase isoforms reveals striking active-site conservation.

Authors:  T O Fischmann; A Hruza; X D Niu; J D Fossetta; C A Lunn; E Dolphin; A J Prongay; P Reichert; D J Lundell; S K Narula; P C Weber
Journal:  Nat Struct Biol       Date:  1999-03

8.  Structural basis for isoform-selective inhibition in nitric oxide synthase.

Authors:  Thomas L Poulos; Huiying Li
Journal:  Acc Chem Res       Date:  2012-10-02       Impact factor: 22.384

Review 9.  Design of selective neuronal nitric oxide synthase inhibitors for the prevention and treatment of neurodegenerative diseases.

Authors:  Richard B Silverman
Journal:  Acc Chem Res       Date:  2009-03-17       Impact factor: 22.384

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  18 in total

1.  Hydrophilic, Potent, and Selective 7-Substituted 2-Aminoquinolines as Improved Human Neuronal Nitric Oxide Synthase Inhibitors.

Authors:  Anthony V Pensa; Maris A Cinelli; Huiying Li; Georges Chreifi; Paramita Mukherjee; Linda J Roman; Pavel Martásek; Thomas L Poulos; Richard B Silverman
Journal:  J Med Chem       Date:  2017-08-04       Impact factor: 7.446

2.  Phenyl Ether- and Aniline-Containing 2-Aminoquinolines as Potent and Selective Inhibitors of Neuronal Nitric Oxide Synthase.

Authors:  Maris A Cinelli; Huiying Li; Anthony V Pensa; Soosung Kang; Linda J Roman; Pavel Martásek; Thomas L Poulos; Richard B Silverman
Journal:  J Med Chem       Date:  2015-10-27       Impact factor: 7.446

3.  Optimization of Blood-Brain Barrier Permeability with Potent and Selective Human Neuronal Nitric Oxide Synthase Inhibitors Having a 2-Aminopyridine Scaffold.

Authors:  Ha T Do; Huiying Li; Georges Chreifi; Thomas L Poulos; Richard B Silverman
Journal:  J Med Chem       Date:  2019-02-25       Impact factor: 7.446

4.  Grape seed proanthocyanidin extract alleviates urethral dysfunction in diabetic rats through modulating the NO-cGMP pathway.

Authors:  Bing Zhang; Zhaocun Zhang; Hong Ji; Hui Shi; Shouzhen Chen; Dongliang Yan; Xuewen Jiang; Benkang Shi
Journal:  Exp Ther Med       Date:  2017-11-13       Impact factor: 2.447

5.  Nitrile in the Hole: Discovery of a Small Auxiliary Pocket in Neuronal Nitric Oxide Synthase Leading to the Development of Potent and Selective 2-Aminoquinoline Inhibitors.

Authors:  Maris A Cinelli; Huiying Li; Georges Chreifi; Thomas L Poulos; Richard B Silverman
Journal:  J Med Chem       Date:  2017-04-19       Impact factor: 7.446

6.  Potent and Selective Human Neuronal Nitric Oxide Synthase Inhibition by Optimization of the 2-Aminopyridine-Based Scaffold with a Pyridine Linker.

Authors:  Heng-Yen Wang; Yajuan Qin; Huiying Li; Linda J Roman; Pavel Martásek; Thomas L Poulos; Richard B Silverman
Journal:  J Med Chem       Date:  2016-04-20       Impact factor: 7.446

Review 7.  Nitric oxide synthase and structure-based inhibitor design.

Authors:  Thomas L Poulos; Huiying Li
Journal:  Nitric Oxide       Date:  2016-11-23       Impact factor: 4.427

8.  Structural and Mechanistic Studies of the Rare Myristoylation Signal of the Feline Immunodeficiency Virus.

Authors:  Janae B Brown; Holly R Summers; Lola A Brown; Jan Marchant; Paige N Canova; Colin T O'Hern; Sophia T Abbott; Constance Nyaunu; Simon Maxwell; Talayah Johnson; Morgan B Moser; Sherimay D Ablan; Hannah Carter; Eric O Freed; Michael F Summers
Journal:  J Mol Biol       Date:  2020-05-19       Impact factor: 5.469

9.  2-Aminopyridines with a Truncated Side Chain To Improve Human Neuronal Nitric Oxide Synthase Inhibitory Potency and Selectivity.

Authors:  Soosung Kang; Huiying Li; Wei Tang; Pavel Martásek; Linda J Roman; Thomas L Poulos; Richard B Silverman
Journal:  J Med Chem       Date:  2015-07-10       Impact factor: 7.446

10.  Improvement of Cell Permeability of Human Neuronal Nitric Oxide Synthase Inhibitors Using Potent and Selective 2-Aminopyridine-Based Scaffolds with a Fluorobenzene Linker.

Authors:  Ha T Do; Heng-Yen Wang; Huiying Li; Georges Chreifi; Thomas L Poulos; Richard B Silverman
Journal:  J Med Chem       Date:  2017-11-01       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.